<DOC>
	<DOCNO>NCT01080820</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability CMX157 amount CMX157 reach blood stream , manner body process CMX157 time take eliminate CMX157 follow one oral dose give healthy volunteer .</brief_summary>
	<brief_title>A Safety , Tolerability Pharmacokinetic Study Single Dose CMX157 Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Tenofovir</mesh_term>
	<criteria>1 . Males females nonchildbearing potential , 18 55 year age . Males must able willing use adequate contraceptive method throughout study . 1 . Currently nurse female , pregnant female , female childbearing potential . 2 . Hypersensitivity tenofovir . 3 . Use antiviral , corticosteroid , immunosuppressive , anticoagulant prescription drug within 4 week prior enrollment . Use prescription drug within 14 day prior enrollment . 4 . Use overthecounter medication , herbal/nutraceutical preparation , within 7 day prior enrollment . 5 . Administration potentially nephrotoxic drug within 14 day prior enrollment . 6 . Use investigational drug and/or treatment within 30 day prior enrollment . 7 . Use illicit drug within 6 month prior screen enrollment , base history urine drug screen . 8 . Infection HIV , HBV HCV . 9 . History abuse alcohol substance ( ) within 6 month prior enrollment . 10 . History symptom cardiovascular disease , include limited coronary artery disease , hypertension , congestive heart disease , cardiomyopathy , cardiac conduction disorder . 11 . History clinically significant hypotension ( include orthostatic ) , faint , lightheadedness . 12 . History gastrointestinal disease impairment . 13 . History renal impairment disorder . 14 . History liver disease impairment . 15 . History cancer , except basal cell carcinoma . 16 . History pathologic bone fracture ; history risk osteopenia 17 . History diabetes , metabolic disease , autoimmune disease ; history immunodeficiency healthy volunteer . 18 . Acute illness fever 38 C within 1 week prior enrollment . 19 . Supine blood pressure systolic outside range 90140 mmHg , diastolic outside range 5090 mmHg . 20 . Resting heart rate &gt; 100 &lt; 45 beat per minute . 21 . Body Mass Index ( BMI ) &gt; 31 &lt; 18 , body weight &lt; 50 kg men &lt; 45 kg woman . 22 . Whole blood donation within 56 day plasma donation within 30 day prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Healthy adult volunteer</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>